Lower Dose of Antithymocyte Globulin (ATG) does not increase Graft-vs-Host Disease (GVHD) in Patients Undergoing Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Stem Cell Transplant (allo HSCT)

The appropriate dose of antithymocyte globulin (ATG) been utilized in reduced-intensity conditioning (RIC) allogeneic hematopoietic stem cell transplantation (alloHSCT) is yet unknown. We retrospectively compared patients who received 7.5 mg/kg (R-ATG – 39 patients) and 6 mg/kg (r-ATG- 97 patients)....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Leuk Lymphoma
Autors principals: Salem, Galena, Ruppert, Amy S., Elder, Patrick, Hofmeister, Craig C., Benson, Don M., Penza, Sam, Andritsos, Leslie, Klisovic, Rebecca, Vasu, Sumithira, Blum, William, Devine, Steven M, Jaglowski, Samantha, Efebera, Yvonne A.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4417073/
https://ncbi.nlm.nih.gov/pubmed/25166008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2014.956314
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars